<!doctype html>
<!--[if lt IE 7]> <html class="lt-ie7" lang="en" prefix="og: http://ogp.me/ns#" xmlns:fb="http://www.facebook.com/2008/fbml"> <![endif]-->
<!--[if IE 7]> <html class="ie7" lang="en" prefix="og: http://ogp.me/ns#" xmlns:fb="http://www.facebook.com/2008/fbml"> <![endif]-->
<!--[if IE 8]> <html class="ie8" lang="en" prefix="og: http://ogp.me/ns#" xmlns:fb="http://www.facebook.com/2008/fbml"> <![endif]-->
<!--[if gt IE 8]><!--> <html lang="en" prefix="og: http://ogp.me/ns#" xmlns:fb="http://www.facebook.com/2008/fbml"> <!--<![endif]-->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />

<!-- this is inside page-default.tpl.php -->
	<title>Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib - FierceBiotech</title>
	<meta name="viewport" content="width=device-width" />

	
	<link type="text/css" rel="stylesheet" media="all" href="http://www.fiercebiotech.com/files/biotech/css/css_706da608889c6bff29b4ed1f59b738b5.css" />
	<script type="text/javascript" src="/sites/all/themes/fierce/js/modernizr.js"></script>
	<script type="text/javascript" src="/sites/all/themes/fierce/js/onmediaquery.js"></script>
	<script type="text/javascript">var mql = Modernizr.mq('only screen and (max-width: 480px)');</script>

	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<script src="http://contentz.mkt912.com/lp/static/js/iMAWebCookie.js?56afc7-1252bf6fd2e-ce240116a00f91fcaa71fbe5df141a8a&h=www.pages01.net" type="text/javascript"></script>
<script type="text/javascript" src="http://servicecenter.fiercemarkets.com/webjs/js?pub_id=1"></script><script type="text/javascript">var LGP_DEMS_fvp = 1;</script>
<!------ OAS SETUP begin ------>
<!--Include OAS Analytics Setup Script -->
<SCRIPT LANGUAGE="JavaScript" src="http://oascentral.fiercemarkets.com/Scripts/oas_analytics.js"></SCRIPT>
<SCRIPT LANGUAGE="JavaScript">
<!--
//configuration
OAS_url = 'http://oascentral.fiercemarkets.com/RealMedia/ads/';
//OAS_sitepage = window.location.hostname + window.location.pathname;
OAS_sitepage = 'fiercebiotech/press-releases/puma-biotechnology-announces-licensing-agreement-pfizer-development-and-com-0';
OAS_listpos = 'Frame1,Right1,Top,Right2,Left1,BottomRight,BottomLeft,Middle1,TopRight';

<!-- Define Custom Reporting Taxonomy, format is: .&Attribute1=Value1&Attribute2=Value2. -->

var OAS_taxonomy='device=desktop';
var OAS_query='device=desktop';

/* handheld */
if(Modernizr.mq('only screen and (max-width: 480px)')) {
  OAS_taxonomy='device=handheld';
  OAS_query='device=handheld';
}
/* handheld */

// this placeholder includes the ampersand
OAS_taxonomy+= '';
OAS_query+='';

if (LGP_DEMS_fvp != null) {
  OAS_taxonomy += '&fvp=' + LGP_DEMS_fvp;
  OAS_query += '&fvp=' + LGP_DEMS_fvp;
}

if (LGP_DEMS != null) {
  OAS_taxonomy += '&' + LGP_DEMS;
  OAS_query += '&' + LGP_DEMS;
}

OAS_query == '' ? OAS_query += 'XE' + '&' + OAS_taxonomy + OAS_rdl + "&if_nt_CookieAccept=" + OAS_CA + '&XE' : OAS_query += '&XE' + '&' + OAS_taxonomy + OAS_rdl + "&if_nt_CookieAccept=" + OAS_CA + '&XE';

OAS_target = '_top';

var fierceIntLogo = 'http://assets.fiercemarkets.net/files/biotech/logo.gif';
var fierceIntSiteName = 'FierceBiotech.com';

//end of configuration
OAS_version = 10;
OAS_rn = '001234567890'; OAS_rns = '1234567890';
OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);

function OAS_NORMAL(pos) {
  document.write('<A HREF="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" TARGET=' + OAS_target + '>');
  document.write('<IMG SRC="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" BORDER=0></A>');
}
//-->
</SCRIPT>

<SCRIPT LANGUAGE="JavaScript1.1">
<!--
OAS_version = 11;
if (navigator.userAgent.indexOf('Mozilla/3') != -1 || navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)
  OAS_version = 10;
if (OAS_version >= 11)
  document.write('<SCR' + 'IPT LANGUAGE="JavaScript1.1" SRC="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/SCRIPT>');//-->
</SCRIPT>

<SCRIPT LANGUAGE="JavaScript">
<!--
document.write('');
function OAS_AD(pos) {
  if (OAS_version >= 11)
    OAS_RICH(pos);
  else
    OAS_NORMAL(pos);
}
//-->
</SCRIPT>
<!------ OAS SETUP end ------>

  <style>.header-info { background: #ffff00; }</style>
<link rel="shortcut icon" href="/favicon.ico" type="image/x-icon" />
<meta property="og:site_name" content="FierceBiotech" />
<meta property="og:title" content="Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib" />
<meta name="description" content="Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and" />
<meta property="og:description" content="Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and" />
<meta name="keywords" content="biotechnology industry,biotech company,clinical trials" />
<meta property="og:image" content="http://assets.fiercemarkets.net/public/opengraphimages/updated/opengraph_fiercebiotech.jpg" />
<meta property="og:type" content="website" />
<link rel="canonical" href="http://www.fiercebiotech.com/press-releases/puma-biotechnology-announces-licensing-agreement-pfizer-development-and-com-0" />
<meta property="og:url" content="http://www.fiercebiotech.com/press-releases/puma-biotechnology-announces-licensing-agreement-pfizer-development-and-com-0" />
<meta name="revisit-after" content="1 day" />

	<meta name="twitter:card" content="summary"/>
<meta name="twitter:site" content="fiercebiotech"/>

	<meta name="apple-itunes-app" content="app-id=714087013"/>
	<script type="text/javascript" src="http://www.fiercebiotech.com/files/biotech/js/js_f6a9627a24d3118181138901eeb64d0b.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls|xml|z|zip"}});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _gaq = _gaq || [];_gaq.push(["_setAccount", "UA-336524-7"]);_gaq.push(['_setCustomVar', 2, 'Authenticated View', '0', 3]);_gaq.push(["_trackPageview"]);(function() {var ga = document.createElement("script");ga.type = "text/javascript";ga.async = true;ga.src = ("https:" == document.location.protocol ? "https://ssl" : "http://www") + ".google-analytics.com/ga.js";var s = document.getElementsByTagName("script")[0];s.parentNode.insertBefore(ga, s);})();
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(document).ready(function() {
  pushercookie = $.cookie('_pusher-box-viewed');
  pusherSuppressed = $.cookie('_pusher_suppressed');

  if (!mql) {
    if(pushercookie != 'yes' && (typeof LGP_PROFILE == "undefined" || !LGP_PROFILE.subscribedTo("FierceBiotech"))) {

      if(pusherSuppressed != 'yes') {
        setTimeout("$('#pusher-ad').slideDown()",1000);
        $.cookie('_pusher-box-viewed', 'yes', { expires: 1, path: '/' });
      }

    } else if(pushercookie == 'yes' && (typeof LGP_PROFILE == "undefined" || !LGP_PROFILE.subscribedTo("FierceBiotech"))) {

      if(pusherSuppressed != 'yes') {
        $('#pusher-ad').css('display', 'block');
      }

    }
  }

});

//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--

$(document).ready(function() {
  $('.js-pusher-closer').click(function() {
    $('#pusher-ad').slideUp(function() {
      var week = 7*24*60*60*1000;
      var expDate = new Date();
      expDate.setTime(expDate.getTime()+week);
      $.cookie('_pusher_suppressed', 'yes', {
        expires: expDate,
        path: '/'
      });
    });
  });
});

//--><!]]>
</script>

	<!--[if lt IE 8]><link rel="stylesheet" type="text/css" href="/sites/all/themes/fierce/fix-ie.css" media="screen"/><![endif]-->
	<!--[if lt IE 7]><link rel="stylesheet" type="text/css" href="/sites/all/themes/fierce/fix-ie6.css" media="screen"/><![endif]-->

	<!-- Home Page Only - jQuery Cycle Initiation -->
	<script type="text/javascript">
	$(document).ready(function() {
		totalSlides = $('.gallery > li').size();
		stopAfter = totalSlides * 4 + 1;
	    $('.gallery').cycle({
			fx: 'fade',
			pager: '#gallery-nav',
			timeout: 7500,
			autostop: 1,
			autostopCount: stopAfter
		});
	});
	</script>

	<!-- Google Plus Button Code -->
	<script type="text/javascript">
	  (function() {
	    var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true;
	    po.src = 'https://apis.google.com/js/plusone.js';
	    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s);
	  })();
	</script>

	<!-- Scrolling social sidebar -->
	<!--<script type="text/javascript" src="/sites/all/themes/fierce/js/jscroll.js"></script>
	<script type="text/javascript">
		$(function() {$("#sharecolumn").jScroll();});
	</script>-->

  <!-- Shadowbox code for slideshow modal dialog box. Ideally this would be added conditionally only to slideshow stories -->
	<script type="text/javascript" src="/sites/all/themes/fierce/js/shadowbox/shadowbox.js"></script>
	<link rel="stylesheet" type="text/css" href="/sites/all/themes/fierce/js/shadowbox/shadowbox.css" />
	<script type="text/javascript">
	if(!mql) {
		Shadowbox.init();
	}
	</script>

	<!-- Carousel code for slideshows only. Ideally would appear conditionally only on slideshow pages -->
	<script type="text/javascript" src="/sites/all/themes/fierce/js/carousel/jquery.jcarousel.min.js"></script>
	<link rel="stylesheet" type="text/css" href="/sites/all/themes/fierce/js/carousel/skins/tango/skin.css" />
	<script type="text/javascript">
	jQuery(document).ready(function() {
	    jQuery('#carousel').jcarousel();
	});
	</script>
	<script type="text/javascript">
	var queries = [
	    {
	        context: 'handheld',
	        callback: function() {
	            //console.log('Mobile callback. Maybe hook up some tel: numbers?');
	            // Your mobile specific logic can go here.
	            removeStuff();
				addStuff();
	        }
	    },
	    {
	        context: 'widescreen',
	        callback: function() {
	            //console.log('skinny callback! Swap the class on the body element.');
	            // Your tablet specific logic can go here.
	            removeStuff();
	        }
	    }
	];
	// Go!
	$(window).load(function() {
		MQ.init(queries);
	});

	</script>
	<script type="text/javascript">

		$(document).ready(function() {
			if(mql) {
				removeStuff();
				addStuff();
			}
		});

		function addStuff() {
			var newNav = '<div id="newNavContainer"><div id="mobile_topics"><a href="/topics">TOPICS</a></div></div>';

						var topicsDrop = '<div id="mobile_topics_menu"><ul><li><a href="/topics/biosimilars">Biosimilars</a></li><li><a href="/topics/chutes-and-ladders">Chutes and Ladders</a></li><li><a href="/topics/clinical-trials">Clinical Trials</a></li><li><a href="/topics/drug-safety">Drug Safety</a></li><li><a href="/topics/emerging-markets">Emerging Markets</a></li><li><a href="/topics/europe">Europe</a></li><li><a href="/topics/ma">M&amp;A</a></li></ul><ul><li><a href="/topics/outsourcing">Outsourcing</a></li><li><a href="/topics/partnering">Partnering</a></li><li><a href="/topics/personalized-medicine">Personalized Medicine</a></li><li><a href="/topics/pipeline">Pipeline</a></li><li><a href="/topics/rd">R&amp;D</a></li><li><a href="/topics/regulatory">Regulatory</a></li><li><a href="/topics/venture-capital">Venture Capital</a></li></div>';
			//console.log(searchBox);
			//$('.search-form-header').css('display', 'none');
			$('.top-panel').after(newNav);
			$('.search-form-header').appendTo('#newNavContainer');
			$(topicsDrop).appendTo('#newNavContainer');
			$('<br class="clear" />').appendTo('#newNavContainer');
			$('#mobile_topics').click(function() {

				if($('#mobile_topics_menu').css('display') == 'block') {
					$('#mobile_topics_menu').css('display', 'none');
				} else {
					$('#mobile_topics_menu').css('display', 'block');
				}

				return false;

			});

			$('.tags').after($('.pane-popular-stories').addClass('box'));
			//$('.pane-popular-stories').addClass('box').after('.tags');
		}
		function removeStuff() {
			$('.top-nav').after($('.search-form-header'));
			$('#newNavContainer').remove();
			$('.mobile-removeable-br').remove();
			//$('.search-form-header').css('display', 'block');
		}
	</script>

</head>
<body>


	<div id="wrapper">
		<div class="w1">
			<div class="w2">
				<div class="w3">




<div id="header">
	<div class="panel-pane pane-site-header" >
  
  
  
  <div class="pane-content">
    <div class="top-panel"><div class="select"><a href="#top_select" class="select_link">Fierce<span>Biotech</span></a><div class="drop" id="top_select"><ul><li><a href="http://www.fiercebiomarkers.com">Fierce<span>Biomarkers</span></a></li><li><a href="http://www.fiercebiotechresearch.com">Fierce<span>BiotechResearch</span></a></li><li><a href="http://www.fiercebiotech.com">Fierce<span>Biotech</span></a></li><li><a href="http://www.fiercebiotechit.com">Fierce<span>BiotechIT</span></a></li><li><a href="http://www.fiercecro.com">Fierce<span>CRO</span></a></li><li><a href="http://www.fiercediagnostics.com">Fierce<span>Diagnostics</span></a></li><li><a href="http://www.fiercedrugdelivery.com">Fierce<span>DrugDelivery</span></a></li><li><a href="http://www.fiercemedicaldevices.com">Fierce<span>MedicalDevices</span></a></li><li><a href="http://www.fiercepharma.com">Fierce<span>Pharma</span></a></li><li><a href="http://www.fiercepharmamanufacturing.com">Fierce<span>PharmaManufacturing</span></a></li><li><a href="http://www.fiercevaccines.com">Fierce<span>Vaccines</span></a></li>
									<li class="more"><a href="#more-fierce-network-sites">More Fierce Network sites</a></li>
								</ul>
								<div class="b"></div>
							</div>
						</div>
						<ul class="top-nav">
							<li class="first active"><a class="top-nav-select-site" href="#top_select">Select another site </a></li>
							<li><a href="http://www.fiercemarkets.com">Advertise</a></li>
							<li><a href="http://www.fiercebiotech.com/contact">Contact</a></li>
						</ul>
						<form method="GET" action="http://www.fiercebiotech.com/search/site" title="search form" class="search-form-header">
							<fieldset>
								<input name="keys" title="search" accesskey="4" class="text" type="text" value="SEARCH" />
								<input class="btn-search" type="submit" value="search" />
							</fieldset>
						</form>
					</div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-leaderboard-row" >
  
  
  
  <div class="pane-content">
    <div class="ad-block"><div class="banner"><SCRIPT LANGUAGE="JavaScript">OAS_AD("Top");</SCRIPT></div><div class="cobweb"><SCRIPT LANGUAGE="JavaScript">!mql ? OAS_AD("TopRight") : "";</SCRIPT></div></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-pusher-ad" >
  
  
  
  <div class="pane-content">
    <div class="header-info" id="pusher-ad" style="display:none;">    <div class="info">
      <div class="info-text"><strong>Free Daily Biotech Industry Newsletter</strong>
Get the latest on Biotech &amp; Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 100,000 biotech professionals who subscribe to <em>FierceBiotech</em> for FREE!
<p><a href="/sample">Click here</a> to see a sample.</p></div>
      <form action="http://www.fiercebiotech.com/offer/signup_web" class="account" method="post">
        <fieldset id="pusher-ad-fieldset">
          <label for="text-1" style="line-height: inherit;">We never sell or give away your contact information. Our readers' trust comes first.<br /><p class="js-pusher-closer"><img src="/sites/all/themes/fierce/img/closer.png" style="vertical-align: middle;" /> </p></label>
          <div class="holder">
            <input type="hidden" name="source" value="Organic-Web_contentpusher-FierceBiotech-FierceBiotech" />
            <input id="text-1" name="email" class="text" type="text" value="EMAIL ADDRESS" />
            <input title="sign me up" class="btn-submit" type="submit" value="SIGN ME UP"/>
          </div>
        </fieldset>
      </form>
    </div>


  </div>
  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-logo-row" >
  
  
  
  <div class="pane-content">
    <div class="header-holder"><a class="logo" accesskey="1" href="http://www.fiercebiotech.com"  title="The Biotech Industry's Daily Monitor"><img src="http://assets.fiercemarkets.net/files/biotech/logo.gif" alt="FierceBiotech" /></a><div class="nav-holder"><ul id="nav"><li class="nav-item nav-item-first-child"  id="item-news"><a href="http://www.fiercebiotech.com/news">NEWS</a></li>
<li class="nav-item" id="item-topics">
<a class="drop-holder">TOPICS</a>
<div class="drop col2">
<div class="c">
<div class="columns">
<div class="col">
<ul>
<li><a href="/topics/biosimilars">Biosimilars</a></li><li><a href="/topics/chutes-and-ladders">Chutes and Ladders</a></li><li><a href="/topics/clinical-trials">Clinical Trials</a></li><li><a href="/topics/drug-safety">Drug Safety</a></li><li><a href="/topics/emerging-markets">Emerging Markets</a></li><li><a href="/topics/europe">Europe</a></li><li><a href="/topics/ma">M&amp;A</a></li><li><a href="/topics/outsourcing">Outsourcing</a></li></ul></div><div class="col"><ul><li><a href="/topics/partnering">Partnering</a></li><li><a href="/topics/personalized-medicine">Personalized Medicine</a></li><li><a href="/topics/pipeline">Pipeline</a></li><li><a href="/topics/rd">R&amp;D</a></li><li><a href="/topics/regulatory">Regulatory</a></li><li><a href="/topics/venture-capital">Venture Capital</a></li></ul></div>	</div>
	</div>
	</div>
	</li>

		<li class="nav-item" id="item-analysis">
		<a class="drop-holder">ANALYSIS</a>
		<div class="drop col1">
		<div class="c">
		<div class="columns">
<div class="col">
<ul>
<li><a href="http://www.fiercebiotech.com/story/download-fiercebiotech-app-iphone-and-ipad/2013-10-03">Download the FierceBiotech app for iPhone and iPad<br><span style="color:#FF6601;">by Arsalan Arif</span></a></li>
<li><a href="http://www.fiercebiotech.com/story/public-citizen-goes-witch-hunt-fda/2013-10-25">Public Citizen goes on a witch hunt at the FDA<br><span style="color:#FF6601;">by John Carroll</span></a></li>
<li><a href="http://www.fiercebiotech.com/special-reports/john-reed-sets-out-long-distance-run-roches-pred">John Reed sets out on a long-distance run at Roche's pRED<br><span style="color:#FF6601;">by John Carroll</span></a></li>
<li><a href="http://www.fiercebiotech.com/special-reports/biotech-ipo-frenzy-headed-crack">Fresh burst of biotech IPO pitches launches a busy Q4 season<br><span style="color:#FF6601;">by John Carroll</span></a></li>
<li><a href="http://www.fiercebiotech.com/story/vc-funding-follows-tepid-pace-q3-first-time-rounds-shrivel/2013-10-18">VC funding follows tepid pace in Q3 as first-time biotech rounds shrivel<br><span style="color:#FF6601;">by John Carroll</span></a></li>
<li><a href="http://www.fiercebiotech.com/tags/industry-voices">Industry Voices<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercebiotech.com/commentary">More Commentary<br><span style="color:#FE6601;"></span></a></li>
</ul>
</div>
		</div>
		</div>
		</div>
		</li>

		<li class="nav-item" id="item-features">
		<a class="drop-holder">FEATURES</a>
		<div class="drop col2">
		<div class="c">
		<div class="columns">
<div class="col">
<ul>
<li><a href="http://www.fiercebiotech.com/special-reports/top-10-biotech-ipos-2013">The top 10 biotech IPOs of 2013</a></li>
<li><a href="http://www.fiercebiotech.com/special-reports/10-top-drugs-biopharmas-late-stage-pipeline">10 top drugs in biopharma's late-stage pipeline</a></li>
<li><a href="http://www.fiercebiotech.com/special-reports/top-15-highest-paid-biopharma-rd-chiefs">Top 15 highest paid biopharma R&D chiefs<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercepharma.com/special-reports/top-10-generics-makers-2012-revenue">Top 10 generics makers by 2012 revenue<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercepharma.com/special-reports/top-10-cardio-drugs-2012">Top 10 Cardio Drugs 2012<br><span style="font-weight:normal;"></span></a></li>
</ul>
</div>
<div class="col">
<ul>
<li><a href="http://www.fiercemedicaldevices.com/special-reports/top-med-tech-investments-q3">Top Med Tech Investments of Q3<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercebiotech.com/special-reports/top-15-biotech-vc-firms">Top 15 Biotech VC Firms<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercepharma.com/special-reports/top-10-pharma-companies-employees">Top 10 Pharma Companies by Employees<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercemedicaldevices.com/special-reports/fiercemedicaldevices-2013-fierce-15">FierceMedicalDevices' 2013 Fierce 15<br><span style="font-weight:normal;"></span></a></li>
<li><a href="http://www.fiercepharma.com/special-reports/top-20-orphan-drugs-2018">Top 20 orphan drugs by 2018<br><span style="font-weight:normal;"></span></a></li>
</ul>
</div>
		</div>
		</div>
		</div>
		</li>
<li class="nav-item"  id="item-library"><a class="drop-holder">LIBRARY</a><div class="drop col1"><div class="c"><div class="columns"><div class="col"><ul><li><a href="http://www.fiercebiotech.com/library/webinars">Webinars</a></li><li><a href="http://www.fiercebiotech.com/library/whitepapers">Whitepapers</a></li><li><a href="http://www.fiercebiotech.com/library/ebooks">eBooks</a></li><li><a href="http://www.fiercebiotech.com/library">View All</a></li></ul></div></div></div></div></li><li class="nav-item"><a href="http://www.fiercebiotech.com/events">EVENTS</a></li><li class="nav-item nav-item-right" id="item-jobs">
		<a class="drop-holder">JOBS</a>
    <div class="drop col1">
			<div class="c">
				<div class="columns">
					<div class="col">
						<ul><li><a href="http://www.fiercebiotech.com/jobs">Browse Jobs</a></li><li><a href="http://www.fiercebiotech.com/jobs/prices">Post a Job</a></li></ul>
					</div>
				</div>
			</div>
		</div>
    </li><li class="nav-item" id="item-marketplace"><a target="_blank" href="http://www.jazdlifesciences.com/pharmatech/?utm_source=fiercebiotech.com&utm_medium=nav&utm_campaign=partner_integration">Marketplace</a></li>			</ul>
			<div class="social">

				<ul>
					<li><a class="e-mail" href="http://www.fiercebiotech.com/signup?source=Organic-Web_followus-FierceBiotech-FierceBiotech" title="Subscribe to our Newsletter">Subscribe</a></li><li><a class="twitter" href="https://twitter.com/#!/FierceBiotech" title="Follow us on Twitter">Twitter</a></li><li><a class="phone" href="http://www.fiercebiotech.com/mobile" title="Try our mobile app">Mobile</a></li></ul>
  <span>Follow US</span>
			</div>
		</div>
	</div>  </div>

  
  </div>
	
</div><!-- end of header -->

<div id="main">
	<div id="twocolumns">
		<div class="twocolumns-holder">
			<div class="twocolumns-frame">
				<div id="content">
					<div class="box">
						<div class="article">
								<div class="panel-pane pane-node-content" >
  
  
  
  <div class="pane-content">
    
  
	<h1>Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib</h1>

	
		<div class="byline"></a></div>

	<div class="body">
				<div class="sharecolumn" id="sharecolumn">

			<div class="share-heading">Share</div>

			<!-- AddThis Column -->
	      	<!-- As API savvy as possible AddThis Column -->
	      	<!--CURRENT FAVORITE-->
	      	<script type="text/javascript">
		      var addthis_share = {
			      	url_transforms: {
						clean: true,
			        	add: {
				           utm_campaign: 'AddThis',
				           utm_medium: 'AddThis',
				           utm_source: '{{code}}'
			            }
			        }
			    }
		      </script>
               <div class="addthis_toolbox addthis_counter_style">
               <a class="addthis_button_email"><img src="/sites/all/themes/fierce/img/addthis_email.png" alt=""></a>
                              <a class="addthis_button_tweet"  tw:count="vertical"></a>
               <a class="addthis_button_linkedin_counter" li:counter="top"></a>
               <a class="addthis_button_facebook_like" fb:like:layout="box_count"></a>
               <a class="addthis_button_google_plusone" g:plusone:size="tall"></a>
               </div>
               <script type="text/javascript" src="http://s7.addthis.com/js/300/addthis_widget.js#pubid=fiercemarkets"></script>
               <!-- AddThis Button END -->
			<div class="tools-heading">Tools</div>
			<ul class="tools">
							<li><a href="/node/201666/print" class="print">Print</a></li>
				                			</ul>

		</div>
				<div class="maincolumn">

			
			<!--paging_filter--><p><strong>Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger</strong></p>
<p>LOS ANGELES, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Puma Biotechnology, Inc., a development stage biopharmaceutical company, today announced an agreement with Pfizer to license the worldwide commercial rights to neratinib, a potent, irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, ErbB1 (EGFR), ErbB2 (HER2) and ErbB4 (HER4) kinases. Neratinib is being studied in the neoadjuvant, adjuvant and metastatic settings in patients with HER2/ErbB2 positive breast cancer.</p>
<p>Under the terms of the agreement, Puma will assume sole responsibility of global product development and commercialization of neratinib. Pfizer will be entitled to receive payments upon Puma's achievement of certain development milestones of neratinib, as well as royalty payments for any sales of neratinib.</p>
<p>Puma intends to focus the development of neratinib on the treatment of patients with HER2-positive locally advanced or metastatic breast cancer who have received prior trastuzumab-based therapy. Neratinib has previously been tested in numerous clinical trials both as single agent and in combination with other anticancer drugs in this patient population. In these studies, neratinib demonstrated substantial clinical activity and was well tolerated. Based on the results of these studies, Puma intends to initiate clinical trials in this patient population in the first half of 2012.</p>
<p>Prior to the licensing agreement with Puma, Pfizer had been sponsoring two clinical trials of neratinib: 1) the NEfERTT trial, a Phase II randomized trial of neratinib in combination with paclitaxel versus trastuzumab in combination with paclitaxel for the treatment of patients who have not received previous treatment for HER2-positive metastatic breast cancer, and 2) the ExteNET trial, a Phase III study investigating the effects of neratinib after adjuvant trastuzumab in patients with early stage breast cancer. Consistent with Puma's strategy to refocus clinical development of neratinib in patients with HER2-positive metastatic breast cancer who have received prior lines of trastuzumab-based therapy, Puma intends to stop enrollment of new patients and proceed with winding down both trials.</p>
<p>Completes $55 Million Private Placement</p>
<p>In addition, Puma announced that it completed a private placement of approximately 14.7 million shares of its common stock to institutional investors that resulted in gross proceeds of approximately $55 million to the company. The shares were issued at a purchase price of $3.75 per share. Leerink Swann LLC acted as sole placement agent for the transaction.</p>
<p>Adage Capital Partners, L.P. was the lead investor in this financing, which also included significant participation from Brookside Capital, H&amp;Q Healthcare Investors HQH +2.23% , H&amp;Q Life Science Investors HQL +2.59% , Jennison Associates LLC, Orbimed Private Investments IV, and funds managed by T. Rowe Price Associates, Inc., as well as a number of other well-known healthcare institutional investors. Proceeds from the private placement will be used primarily to fund the continued clinical development of neratinib.</p>
<p>In conjunction with the private placement, Puma completed a reverse merger with Innovative Acquisitions, Inc. ("Innovative Acquisitions"), a public reporting company with no prior business operations. The transaction was completed by the merger of a wholly-owned subsidiary of Innovative Acquisitions with Puma that resulted in Puma remaining as the surviving company and a wholly-owned operating subsidiary of Innovative Acquisitions. Immediately after the initial merger, Puma was merged directly into Innovative Acquisitions, and this resulted in Innovative Acquisitions surviving. Stockholders of the former Puma (including those that participated in the private placement) received shares of Innovative Acquisitions in exchange for their Puma shares, and the former Puma stockholders now hold 100 percent of the resulting company's equity in the same proportion as such stockholders owned immediately following the precedent private placement. Further, the officers and directors of Puma, pre-merger, replaced all of the officers and directors of Innovative Acquisitions. Subsequently, Innovative Acquisitions was renamed Puma Biotechnology Inc. The resulting company has adopted and will implement the pre-merger business plan of Puma and will continue to be a public reporting company.</p>
<p>Alan H. Auerbach, Chief Executive Officer, President and Founder of Puma stated, "We are pleased to be able to complete this licensing agreement with Pfizer for neratinib. To date, neratinib has demonstrated strong evidence of antitumor activity, both as a single agent and in combination with other anticancer drugs, in patients with HER2-positive locally advanced or metastatic breast cancer who have received prior lines of treatment that include trastuzumab-based therapy. We look forward to the continued development of neratinib in this patient population." Mr. Auerbach further added, "We are additionally pleased to be able to close this private placement with such a leading group of institutional healthcare investors. We expect the proceeds from this financing will allow us to move forward expeditiously with the clinical development of neratinib."</p>
<p>About Puma Biotechnology</p>
<p>Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.</p>
<p>Further information about Puma Biotechnology can be found at www.pumabiotechnology.com .</p>
<p>Forward-Looking Statements:</p>
<p>This press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. These risks include, among other things, that the Company has no product revenue and no products approved for marketing, the Company's dependence on its lead drug candidate, which is still under development and may never receive regulatory approval, the challenges associated with conducting and enrolling clinical trials, the risk that the results of clinical trials may not support the Company's drug candidate claims, even if approved, the risk that physicians and patients may not accept or use the Company's products, the Company's reliance on third parties to conduct its clinical trials and to formulate and manufacture its drug candidates and the Company's dependence on licensed intellectual property. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to update these forward-looking statements, except as required by law.</p>
<p>Contacts:Alan H. Auerbach, Puma Biotechnology, Inc. +1 310 443 4150info@pumabiotechnology.com</p>
<p>&nbsp;</p>			<div class="clear"></div>

      
			
			
		</div><!-- main column -->
		<div class="clear"></div>
	</div><!-- body -->

  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-mobiletopbigbox" >
  
  
  
  <div class="pane-content">
    <div class="ad-bigbox"><SCRIPT LANGUAGE="JavaScript">mql ? OAS_AD("Right1") : "";</SCRIPT></div>  </div>

  
  </div>
						</div>
					</div>
					
				</div>
				<div id="sidebar">
					<div class="panel-pane pane-subscribe-box" >
  
  
  
  <div class="pane-content">
    <form action="http://www.fiercebiotech.com/offer/signup_web" class="account" method="post">
  <fieldset class="subscribe-bottom">
    <h3>
      <span style="font-size:19px;">Join 100,000+ Insiders</span>
      <strong>SIGN UP FOR OUR</strong>
      NEWSLETTER
    </h3>
    <div class="row">
      <input title="EMAIL ADDRESS" id="text-2" class="text" name="email" type="text" value="EMAIL ADDRESS" />
      <input title="SIGN ME UP" class="btn-submit" type="submit" value="SIGN ME UP"/>
      <input type="hidden" name="source" value="Organic-Web_story_page-FierceBiotech-FierceBiotech" />
    </div>
    <label for="text-2"><em>FierceBiotech</em> is the drug development industry's news monitor, covering biopharma deals, clinical trials, FDA decisions, and more. Subscribe to our free daily email and join the largest, most influential biotechnology news audience in the world. Sign up today!</label>
  </fieldset>
</form>

  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-topbigbox" >
  
  
  
  <div class="pane-content">
    <div class="ad-bigbox"><SCRIPT LANGUAGE="JavaScript">!mql ? OAS_AD("Right1") : "";</SCRIPT></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-popular-stories" >
  
      <div class="title"><strong class="pane-title">Popular Stories</strong></div>
  
  
  <div class="pane-content">
    <div class="popular_stories"><ul class="popular_stories_tabs"><li><a href="#popular_most_read" class="active">Most Read</a></li><li><a href="#popular_most_shared">Most Shared</a></li></ul><div class="most-read" id="popular_most_read"><ul><li><a href="http://www.fiercebiotech.com/story/new-era-hep-c-treatment-begins-fda-ok-sofosbuvir/2013-12-06">UPDATED: New era for hep C treatment begins with FDA OK for Gilead&#039;s sofosbuvir</a></li><li><a href="http://www.fiercebiotech.com/story/ariad-faces-fresh-woe-ema-takes-harder-look-iclusig/2013-12-06">Ariad faces fresh woe as EMA takes a harder look at Iclusig</a></li><li><a href="http://www.fiercebiotech.com/story/novartis-hits-phiii-paydirt-promising-myeloma-drug/2013-12-06">Novartis hits PhIII paydirt with promising myeloma drug</a></li><li><a href="http://www.fiercebiotech.com/story/idenix-fires-shot-patent-battle-over-gileads-sofosbuvir/2013-12-02">Idenix fires off a shot in patent battle over Gilead&#039;s sofosbuvir</a></li><li><a href="http://www.fiercebiotech.com/story/geron-soars-marrow-cancer-drug-shines-early-study/2013-12-06">Geron soars as marrow cancer drug shines in preliminary results</a></li></ul></div><div class="most-shared" id="popular_most_shared"><ul><li><a href="http://www.fiercebiotech.com/story/flagship-ventures-ceo-keeps-merck-aboard-inform-biotech-bets/2012-09-25">Flagship Ventures CEO keeps Merck aboard to inform biotech bets</a></li><li><a href="http://www.fiercebiotech.com/story/gilead-charts-phiii-success-leukemia-drug-jj-showdown-awaits/2013-11-19">Gilead charts PhIII success for leukemia drug as J&amp;amp;J showdown awaits</a></li><li><a href="http://www.fiercebiotech.com/story/new-era-hep-c-treatment-begins-fda-ok-sofosbuvir/2013-12-06">UPDATED: New era for hep C treatment begins with FDA OK for Gilead&#039;s sofosbuvir</a></li><li><a href="http://www.fiercebiotech.com/story/roche-partners-molecular-partners-armed-proteins-1b-plus-deal/2013-12-04">Roche teams with Molecular Partners on armed proteins in $1B-plus deal</a></li><li><a href="http://www.fiercebiotech.com/story/big-pharma-agrees-widen-access-clinical-trial-data/2013-07-24">Big Pharma agrees to widen access to clinical trial data</a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-library-stack" >
  
  
  
  <div class="pane-content">
    <div class="library-stack-block"><h3>THE LIBRARY: EBOOK</h3><span class="library-stack-link"><a href="http://www.fiercebiotech.com/offer/datamining?source=listing">Picking Winners: Data Mining for Drug Discovery</a></span><p><a href="http://www.fiercebiotech.com/offer/datamining?source=listing"><img class="library_icon" src="http://assets.fiercemarkets.net/public/library/ebook.gif" alt="" align="left" style="padding: 5px;" /></a><span class="library_meta"> | Sponsored by: Certara</span><p>There are several new initiatives being undertaken in the biopharmaceutical industry aimed at making better use of the vast terabytes of information flowing out of research labs around the world. This ebook discusses the intelligent application of analytics and informatics to enable drug hunters to better understand disease, pharmacological and clinical data. <a href="http://www.fiercebiotech.com/offer/datamining?source=listing">Download it today.</a></p></p><p><a class="more" href="http://www.fiercebiotech.com/library">MORE ITEMS</a></p></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-bottombigbox" >
  
  
  
  <div class="pane-content">
    <div class="ad-bigbox"><SCRIPT LANGUAGE="JavaScript">!mql ? OAS_AD("Right2") : "";</SCRIPT></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-views-panes pane-commentary-panel-pane-1" >
  
      <div class="title"><strong class="pane-title">Latest Commentary</strong></div>
  
  
  <div class="pane-content">
    <div class="view view-commentary view-id-commentary view-display-id-panel_pane_1 view-dom-id-fbc5b4d381c72afacc42a21453568853">
      
  
      <div class="view-content">
        <div class="views-row views-row-1 views-row-odd views-row-first">
      
  <div class="views-field views-field-title">        <span class="field-content"><a href="/story/meet-new-publisher/2013-11-20">Meet the new publisher</a></span>  </div>  </div>
  <div class="views-row views-row-2 views-row-even">
      
  <div class="views-field views-field-title">        <span class="field-content"><a href="/story/public-citizen-goes-witch-hunt-fda/2013-10-25">Public Citizen goes on a witch hunt at the FDA</a></span>  </div>  </div>
  <div class="views-row views-row-3 views-row-odd">
      
  <div class="views-field views-field-title">        <span class="field-content"><a href="/special-reports/biotech-ipo-frenzy-headed-crack">UPDATED: Fresh burst of biotech IPO pitches launches a busy Q4 season</a></span>  </div>  </div>
  <div class="views-row views-row-4 views-row-even">
      
  <div class="views-field views-field-title">        <span class="field-content"><a href="/story/vc-funding-follows-tepid-pace-q3-first-time-rounds-shrivel/2013-10-18">VC funding follows tepid pace in Q3 as first-time biotech rounds shrivel</a></span>  </div>  </div>
  <div class="views-row views-row-5 views-row-odd views-row-last">
      
  <div class="views-field views-field-title">        <span class="field-content"><a href="/story/download-fiercebiotech-app-iphone-and-ipad/2013-10-03">Download the FierceBiotech app for iPhone and iPad</a></span>  </div>  </div>
    </div>
  
  
  
      
<div class="more-link">
  <a href="/commentary">
    more  </a>
</div>
  
  
  
</div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-events-list" >
  
  
  
  <div class="pane-content">
    <div class="events-block"><h3>EVENTS</h3><ul class="events-list"><li><a class="event" href="http://www.cbinet.com/conference/pc14057?cid=ELMMPC14057FierceMarkets">Clinical Data Disclosure and Transparency</a>January 30-31, 2014 &mdash; Philadelphia, Pennsylvania</li><li><a class="event" href="http://www.shu-law.com/?source=DMemail&sourcetype=DMbanner&sourcecode=FBeventlisting112013">Online Graduate Certificates in Intellectual Property Law</a></li></ul><a class="more" href="http://www.fiercebiotech.com/events">MORE EVENTS</a></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-buttons" >
  
  
  
  <div class="pane-content">
    <div class="ad-button"><SCRIPT LANGUAGE="JavaScript">!mql ? OAS_AD("BottomLeft") : "";</SCRIPT></div> &nbsp; <div class="ad-button"><SCRIPT LANGUAGE="JavaScript">!mql ? OAS_AD("BottomRight") : "";</SCRIPT></div>  </div>

  
  </div>
				</div>
			</div>
		</div>
	</div>
	<div class="block-links">
		<div class="columns">
			<div class="col col2">
				<div class="panel-pane pane-jazd-hottest-products" >
  
      <div class="title"><strong class="pane-title">Press Releases</strong></div>
  
  
  <div class="pane-content">
    <ul class="press_releases"><li class="press_release-title"><a href="http://www.fiercebiomarkers.com/press-releases/prostate-cancer-biomarker-may-predict-patient-outcomes">Prostate cancer biomarker may predict patient outcomes </a></li><li class="press_release-title"><a href="http://www.fiercebiotechit.com/press-releases/10-million-competition-business-map-rare-cancer-genes">£10 million competition for business to map rare cancer genes</a></li><li class="press_release-title"><a href="http://www.fiercecro.com/press-releases/agilux-laboratories-announces-space-expansion-support-increasing-demand-its">Agilux Laboratories Announces Space Expansion to Support Increasing Demand for Its In Vivo Pharmacokinetics Services</a></li><li class="press_release-title"><a href="http://www.fiercebiotechit.com/press-releases/frost-sullivan-three-big-predictions-global-healthcare-market">Frost &amp; Sullivan: The Three Big Predictions for the Global Healthcare Market </a></li><li class="press_release-title"><a href="http://www.fiercebiotechit.com/press-releases/deloitte-life-science-rd-earning-its-investment">Deloitte: is life science R&amp;D earning its investment?</a></li><li><a href="http://www.fiercebiotech.com/press-releases">More Press Releases</a></li></ul>  </div>

  
  </div>
			</div>
			<div class="col col2">
				<div class="panel-pane pane-jobs" >
  
      <div class="title"><strong class="pane-title">Featured Jobs</strong></div>
  
  
  <div class="pane-content">
    <div class="item-list">
<ul>
					<li class="fiercelink">
				<strong><a href="http://www.fiercebiotech.com/jobs/job/64923/scientist-medicinal-chemistry-temporary-positions-available-at-flexus-biosciences-inc/">Scientist, Medicinal Chemistry (Temporary Positions Available)</a></strong><br/> Flexus Biosciences, Inc.  - San Carlos CA			</li>
					<li class="fiercelink">
				<strong><a href="http://www.fiercebiotech.com/jobs/job/64228/senior-director-talent-and-leadership-job-at-celgene-corporation/">Senior Director, Talent and Leadership Job</a></strong><br/> Celgene Corporation - US			</li>
					<li class="fiercelink">
				<strong><a href="http://www.fiercebiotech.com/jobs/job/65250/senior-director-toxicology-at-citoxlab-north-america/">Senior Director, Toxicology</a></strong><br/> CiToxLAB North America - Laval			</li>
					<li class="fiercelink">
				<strong><a href="http://www.fiercebiotech.com/jobs/job/63187/vice-president-global-medical-affairs-multiple-myeloma-job-at-celgene-corporation/">Vice President, Global Medical Affairs - Multiple Myeloma Job</a></strong><br/> Celgene Corporation - Summit NJ US			</li>
					<li class="fiercelink">
				<strong><a href="http://www.fiercebiotech.com/jobs/job/65009/director-regulatory-affairs-cmc-13000003ma-at-abbvie/">Director, Regulatory Affairs CMC - 13000003MA</a></strong><br/> Abbvie - Chicago IL United States			</li>
			
</ul>
</div>  </div>

  
  </div>
			</div>
			<div class="col col2">
							</div>
		</div>
	</div>
</div>

<div class="panel-pane pane-mobilebottombigbox" >
  
  
  
  <div class="pane-content">
    <div class="ad-bigbox"><SCRIPT LANGUAGE="JavaScript">mql ? OAS_AD("Right2") : "";</SCRIPT></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-site-footer" >
  
  
  
  <div class="pane-content">
    <div id="footer"><div class="footer-holder"><div class="col-1"><h4>A publication of<span class="logo"><a href="http://www.fiercemarkets.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMarkets</a></span></h4><div class="brand_description"><em>FierceBiotech</em> monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 100,000 biotech industry leaders who subscribe to our free daily email.&nbsp;<a href="http://www.fiercebiotech.com/signup?sourceform=Organic-Web_description-FierceBiotech-FierceBiotech">Click here</a> to get your free weekly email briefing today!</div></div><div class ="col-2"><h4 id="more-fierce-network-sites">The FierceMarkets Network:</h4><div class="columns"><div class="col"><h5>Telecom</h5><ul class="list-links"><li><a href="http://www.fiercecable.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceCable</a></li><li><a href="http://www.fiercedeveloper.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceDeveloper</a></li><li><a href="http://www.fiercewireless.com/europe?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceWireless:Europe</a></li><li><a href="http://www.fiercewireless.com/tech/?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceWirelessTech</a></li><li><a href="http://www.fierceonlinevideo.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceOnlineVideo</a></li><li><a href="http://www.fiercetelecom.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceTelecom</a></li><li><a href="http://www.fiercewireless.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceWireless</a></li></ul><h5>Marketing &amp; Retail</h5><ul class="list-links"><li><a href="http://www.fiercecmo.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceCMO</a></li><li><a href="http://www.fierceretail.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceRetail</a></li><li><a href="http://www.fierceretail.com/mobileretail?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMobileRetail</a></li><li><a href="http://storefrontbacktalk.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">StorefrontBacktalk</a></li></ul></div><div class="col"><h5>Healthcare</h5><ul class="list-links"><li><a href="http://www.fierceemr.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceEMR</a></li><li><a href="http://www.fiercehealthcare.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceHealthcare</a></li><li><a href="http://www.fiercehealthfinance.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceHealthFinance</a></li><li><a href="http://www.fiercehealthit.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceHealthIT</a></li><li><a href="http://www.fiercehealthpayer.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceHealthPayer</a></li><li><a href="http://www.fiercemedicalimaging.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMedicalImaging</a></li><li><a href="http://www.fiercemobilehealthcare.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMobileHealthcare</a></li><li><a href="http://www.fiercepracticemanagement.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FiercePracticeManagement</a></li><li><a href="http://www.hospitalimpact.org?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">Hospital Impact</a></li></ul><h5>Government</h5><ul class="list-links"><li><a href="http://www.fiercegovernment.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceGovernment</a></li><li><a href="http://www.fiercegovernmentit.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceGovernmentIT</a></li><li><a href="http://www.fiercehomelandsecurity.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceHomelandSecurity</a></li><li><a href="http://www.fiercemobilegovernment.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMobileGovernment</a></li></ul></div><div class="col"><h5>Energy</h5><ul class="list-links"><li><a href="http://www.fierceenergy.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceEnergy</a></li><li><a href="http://www.fiercesmartgrid.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceSmartGrid</a></li></ul><h5>Life Sciences </h5><ul class="list-links"><li><a href="http://www.fiercebiomarkers.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceBiomarkers</a></li><li><a href="http://www.fiercebiotechresearch.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceBiotechResearch</a></li><li><a href="http://www.fiercebiotech.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceBiotech</a></li><li><a href="http://www.fiercebiotechit.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceBiotechIT</a></li><li><a href="http://www.fiercecro.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceCRO</a></li><li><a href="http://www.fiercediagnostics.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceDiagnostics</a></li><li><a href="http://www.fiercedrugdelivery.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceDrugDelivery</a></li><li><a href="http://www.fiercemedicaldevices.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMedicalDevices</a></li><li><a href="http://www.fiercepharma.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FiercePharma</a></li><li><a href="http://www.fiercepharmamanufacturing.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FiercePharmaManufacturing</a></li><li><a href="http://www.fiercevaccines.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceVaccines</a></li></ul></div><div class="col"><h5>Enterprise IT</h5><ul class="list-links"><li><a href="http://www.fiercebigdata.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceBigData</a></li><li><a href="http://www.fiercecio.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceCIO</a></li><li><a href="http://www.fiercecio.com/techwatch?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceCIO:TechWatch</a></li><li><a href="http://www.fiercecontentmanagement.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceContentManagement</a></li><li><a href="http://www.fierceenterprisecommunications.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceEnterprise<wbr>Communications</a></li><li><a href="http://www.fierceitsecurity.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceITSecurity</a></li><li><a href="http://www.fiercemobileit.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceMobileIT</a></li></ul><h5>Finance</h5><ul class="list-links"><li><a href="http://www.fierceCFO.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceCFO</a></li><li><a href="http://www.fiercefinance.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceFinance</a></li><li><a href="http://www.fiercefinanceit.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">FierceFinanceIT</a></li></ul></div></div></div></div><ul class="footer-nav"><li><a href="http://www.fiercebiotech.com">Home</a></li><li><a href="http://www.fiercebiotech.com/offer/signup?source=Organic-Web_Site_Footer-FierceBiotech-FierceBiotech">Subscribe</a></li><li><a href="http://memberservices.fiercemarkets.com/">Manage Newsletter Subscriptions</a></li><li><a href="http://www.fiercemarkets.com?utm_source=FierceBiotechfooter&utm_medium=footer&utm_campaign=footer">Advertise</a></li><li><a href="http://www.fiercebiotech.com/contact">Contact</a></li><li><a href="http://www.fiercebiotech.com/mobile">Mobile Apps</a></li><li><a href="http://www.fiercebiotech.com/feed">RSS</a></li><li><a href="http://www.fiercemarkets.com/about_us/privacy_policy">Privacy</a></li><li><a href="http://www.fiercebiotech.com/editors">Editors</a></li><li><a href="http://www.jazdlifesciences.com/pharmatech/suppliers/?utm_source=fiercebiotech.com&utm_medium=footer&utm_campaign=partner_integration">List in Marketplace</a></li></ul><span class="copy">&copy; 2013 FierceMarkets. All rights reserved.</span></div><!-- You will make all kinds of mistakes; but as long as you are generous and true and also fierce you cannot hurt the world or even seriously distress her. --Winston Churchill -->  </div>

  
  </div>




				</div>
				<div class="wrapper-b"></div>
			</div>
		</div>
	</div>

	
	
  <script src="http://static.getclicky.com/js" type="text/javascript"></script>
  <script type="text/javascript"><!--//--><![CDATA[//><!--
  clicky.init(66488010);
  //--><!]]></script>
  <noscript><p><img alt="Clicky" src="http://static.getclicky.com/66488010ns.gif" /></p></noscript>
<div class="ad-interstitial"><SCRIPT LANGUAGE="JavaScript">!mql ? OAS_AD("Frame1") : "";</SCRIPT></div><script type="text/javascript">
<!--//--><![CDATA[//><!--
var _bizo_data_partner_id = "639";

//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _bizo_p = (("https:" == document.location.protocol) ? "https://sjs." : "http://js.");
document.write(unescape("%3Cscript src='" + _bizo_p + "bizographics.com/convert_data.js?partner_id=" + _bizo_data_partner_id + "' type='text/javascript'%3E%3C/script%3E"));

//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(document.location.protocol=='http:'){var Tynt=Tynt||[];Tynt.push('cXmCzQGdSr3Ohiab7jrHtB');Tynt.o={"el":"Subscribe at <a style='color: #003399;' href='http://www.fiercebiotech.com/signup?sourceform=Viral-Tynt-FierceBiotech-FierceBiotech' target='_blank'>FierceBiotech</a>"};(function(){var s=document.createElement("script");s.async="async";s.type="text/javascript";s.src="http://tcr.tynt.com/ti.js";var h=document.getElementsByTagName("script")[0];h.parentNode.insertBefore(s,h);})();}

//--><!]]>
</script>
</body>
</html>
